Who to call at SOLENO THERAPEUTICS, INC., and when
Fundz watches for the moments SOLENO THERAPEUTICS, INC. starts buying, and tells you who to reach.
- An alert the day SOLENO THERAPEUTICS, INC. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SOLENO THERAPEUTICS, INC., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SOLENO THERAPEUTICS, INC.. With Fundz connected, it knows.
SOLENO THERAPEUTICS, INC.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
soleno.lifeAI Executive Summary
AI-powered analysis of 8-K filing content
Soleno Therapeutics expanded its Board of Directors on October 13, 2025 by appointing Mark W. Hahn as a Class II director and Audit Committee member, with a term expiring at the 2028 annual meeting. The appointment adds a director with substantial pharmaceutical CFO experience to the audit oversight function.
Key Takeaways
Mark W. Hahn was appointed as a Class II director and joined the Audit Committee, with his term expiring at the 2028 annual stockholder meeting.
The board was expanded, so this is an addition to the existing board rather than a replacement of a departing director.
3 more takeaways
Related Filings (7)
7 more filings from SOLENO THERAPEUTICS, INC. in the last 90 days
Filing Overview
What This Means
SOLENO THERAPEUTICS, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.